- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01695213
RCT Comparing the DEXA Results of the HA-Omnifit Versus the Symax Uncemented Hip Stem
A Randomized Comparative Study to Evaluate the Performance and Confirm the Safety of the Diocom Hip Syhstem in Cementless Hip Arthroplasty
Study Overview
Status
Intervention / Treatment
Detailed Description
It is of great importance for the function of uncemented total hip arthroplasty that the anchorage of the prosthesis in the bone of the femur is sufficient. This is of great importance in the prevention of stress shielding of the bone and to insure tranfer of forces from the prosthesis to the femur.
The symax hip stem is developed to optimize stress tranfer to bone and insure mechanical stability.
In this study the symax hip stem is compared to the HA_Omnifit hip stem (a frequently used and long term evaluated uncemented hip prosthesis) During the fist two years of follow up DEXA mesurments of bone mineral density are performed. Also patient satisfaction, patient fuction score and radiological evaluation measurements are done during 5 years of follow up.
Our primary objective is: comparison of the short term bone remodelling surrounding the Symax hip stem to the short term remodeling surrounding the Stryker Omnifit HA hip stem measured by bone densitometry, clinical and radiographic evaluation.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:Male or non pregnant female patients >18 years
- Patient with degenerative or traumatic changes to hip requiring hip replacement
- Patient with BMI<35
- Patient signed informed consent
Exclusion Criteria:
- chronic anti-inflammatory medication use> 3 months
- revision surgery to the affected femur
- Cancer therapy including immunosuppression, chemotherapy and radiation
- Pathological fractures, delayed ossification or non-union is likely to occur
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: HA-Omnifit
Patients who receive a HA-Omnifit uncemented hip stem
|
|
Active Comparator: Symax hip stem
Patients with the Symax uncemented hip stem
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
short term bone remodeling
Time Frame: 6 times within 2 years
|
Bone remodeling is determined by measuring the Bone mineral density during time
|
6 times within 2 years
|
complications and reoperations
Time Frame: during 5 years
|
Reporting all complications and reoperations of the two different hip prostheses
|
during 5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
clinical performance
Time Frame: 9 times within 5 years
|
Comparison of the clinical performance of the two different hip prostheses
|
9 times within 5 years
|
Radiological evaluation
Time Frame: 9 times within 5 years
|
Evaluation of Xrays according to the engh classifications
|
9 times within 5 years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
patient satisfaction
Time Frame: 9 times within 5 years
|
comparison of patient satisfaction between the two different prostheses
|
9 times within 5 years
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Lodewijk van Rhijn, azM
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Symax DEXA study
- MEC 02-072 (Other Identifier: METC MUMC Maastricht)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patients With Osteoarthritis of the Hip Joint Elligable for a Uncemented Hipprosthesis
-
Health NavigatorVastra Gotaland Region; Region Stockholm; Ostergotland County Council, Sweden; Uppsala...UnknownThe Focus is to Investigate Effects of a Disease Management Intervention for Patients With Congestive Heart FailureSweden
-
Zimmer BiometActive, not recruitingAvascular Necrosis | Inflammatory Arthritis | Osteoarthritis, Hip | Congenital Hip Dysplasia | Post-traumatic; Arthrosis | Rheumatoid Arthritis With Adequate Bone QualityNetherlands, Finland, Belgium, France, Spain, Australia, Canada, United Kingdom
Clinical Trials on uncemented total hip arthroplasty
-
DePuy OrthopaedicsCompletedOsteoarthritis; Rheumatoid Arthritis; Post Traumatic ArthritisUnited States, Netherlands, Italy, United Kingdom
-
Sahlgrenska University Hospital, SwedenStryker NordicUnknown
-
Sahlgrenska University Hospital, SwedenDePuy OrthopaedicsCompletedFemoral Neck FracturesSweden
-
Spaarne GasthuisRecruitingRheumatoid Arthritis | Knee Osteoarthritis | Osteoarthritis, Knee | Knee RheumatismNetherlands
-
Smith & Nephew, Inc.RecruitingAdvanced Degeneration of the Hip Joint | Revision of the Hip JointUnited States, Canada, Australia, Hong Kong, India
-
Suzhou MicroPort OrthoRecon Co. LTDCompleted
-
Orthopedic Hospital Vienna SpeisingCompletedTotal Hip ArthroplastyAustria
-
DePuy OrthopaedicsTerminatedOsteoarthritis | Degenerative Arthritis | Revision ArthroplastyCanada
-
Rothman Institute OrthopaedicsCompleted
-
Istituto Clinico HumanitasCompleted